Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-07

Clinical Trial Update: Buprenorphine as a Treatment in Opiate Dependent Pain Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating buprenorphine for patients with opioid use disorder and refractory pain was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Opiate Addiction, Refractory Pain | Phase 4 | Status: TERMINATED | Results posted: 2009-07-07